Roche and Ascidian agree to $1.8bn neurological disease partnership
8-9 News
Researchers identify new major cause of inflammatory bowel disease
10-11 Dermatology News
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
12 DARWIN'S MEDICINE - Traitorous doubts
The evolutionary lessons for Bayer’s management restructure
13 MIKE DIXON - Cameras on…
Collecting the right data in the right way for the right reasons
14 INNOVATIVE IMPACT BLOG - Leveraging AI to supercharge early commercialisation strategy
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
15 HEALTHCARE: Beyond the badge: communicating the business case for DEI
16-17 AI AND ALZHEIMER’S - Alzheimer’s disease – the silent pandemic and the positive impact of AI
Across almost every sector, brands are multiplying their investment in creativity
18 TL ICON - Mitigating barriers to recruitment and retention in early stage Alzheimer’s trials
19 ADVERTORIAL VISIONS4HEALTH - DCODE: your gateway to accelerating local innovation adoption in the
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
20-22 SEPSIS AND AMR - Sepsis and the impact of antibiotic resistance
Picking your omnichannel direction requires a disciplined, scientific approach
23 TL INIZIO MEDICAL - Innovation with intention: balancing scientific progress and patient-centric
24-26 ASCO 2025 – bringing a sense of urgency to the war against cancer
27 PME highlights
28-30 HCP ENGAGEMENT AND AI - Communicating with HCPs through AI takes finesse, flexibility and
31 ADVERTORIAL MEDSCAPE GLOBAL - The value of Medscape Extend – redefining omnichannel engagement wi
32 TL S V SYNERGY VISION - More than digital: prioritising the human element in HCP engagem
33 TL VEEVA - Winning commercial’s AI race with connected CRM and data
34-35 US TARIFFS AND MANUFACTURING - Why tariffs could fuel a new era of domestic pharma manufacturi
36-37 BIOTECH MARKET CHALLENGES - Current market challenges are redefining the biotech landscape
38 FlyPharma AMSTERDAM 2025
39 - HEALTHCRAE COMMS
40 Appointments
41 Appointments
42 Appointments
43 CANCER RESEARCH CENTRE – Plans submitted for £1bn cancer research and treatment centre in London
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’